|
|
Dermatology
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis Principal Investigator: Amy Paller, MD Contact: Anne Mahoney, MD Phone: 773-327-3326 E-mail: AMahoney@childrensmemorial.org ClinicalTrials.gov Identifier: NCT00879944; IRB Number: 2009-13793
Open-label, Pilot study to Investigate the Safety and Tolerability of Alwextin 3.0% Cream in the Treatment of Epidermolysis Bullosa Principal Investigator: Amy Paller, MD Contact: Amanda Silverio, MD Phone: (773) 327-9642 E-mail: ASilverio@childrensmemorial.org ClinicalTrial.gov Identifier: NCT00825565; IRB Number 2009-13625
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy (HEMANGIOL) Principal Investigator:Anthony J. Mancini, MD Contact: Anne Mahoney, MD Phone: (773) 327-3326 E-mail: AMancini@northwestern.edu; AMahoney@childrensmemorial.org ClinicalTrials.gov Identifier: NCT01056341; IRB Number 2010
Genetic Screening for Filaggrin mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Popluation Principal Investigator: Amy Paller, MD Contact: Amanda Silverio, MD Phone: (773) 327-9642 E-mail: ASilverio@childrensmemorial.orgClinicalTrials.gov Identifier: NCT01016106; IRB Number 2010-14049
ADVN Biomarker Registry Study Condition: Atopic Dermatitis Principal Investigator: Amy Paller, MD Contact: Anne Mahoney,MD Phone: 773-327-3326 Email: AMahoney@childrensmemorial.org ClinicalTrials.gov identifier: NCT00550316; IRB Number: 2008-13500/13508
Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis (Genetics) Principal Investigator: Amy Paller, MD Contact: Anne Mahoney. MD Phone: 773-327-3326 Email: AMahoney@childrensmemorial.org ClinicalTrials.gov identifier: NCT00515047
Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris Principal Investigator: Amy Paller, MD Contact: Amanda Silverio, MD Phone: (773) 327-9642 E-mail: ASilverio@childrensmemorial.org ClinicalTrials.gov Identifier: NCT00817219
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa Principal Investigator: Amy Paller, MD Contact: Anne Mahoney, MD Phone: (773) 327-3326 E-mail: AMahoney@childrensmemorial.org ClinicalTrials.gov Identifier: NCT00311766; IRB # 2006-12938
An Open-label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects with Plaque Psoriasis Principal Investigator: Amy Paller, MD Contact Person : Amanda Silverio, MD Phone number: 773-327-9642Email: ASilverio@childrensmemorial.org ClinicalTrials.gov Identifier: NCT00141921 (IRB Number: 2005-12643)
Genetic Screening for Dermatologic Diseases Principal Investigator: Amy Paller, MD Contact Person: Amanda Silverio, MD Email: ASilverio@childrensmemorial.org Phone number: 773-327-9642 IRB Number: 2009-13803
A Pilot Study of reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) in Children with Recessive Dystrophic Epidermolysis Bullosa (RDEB)Principal Investigator: Amy Paller, MD Contact Person: Anne Mahoney, MD Email: AMahoney@childrensmemorial.org Phone number: 773-327-3326 IRB Number: 2009-13907
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis. Principal Investigator: Amy Paller, MD Contact Person: Amanda Silverio, MD Email: ASilverio@childrensmemorial.org Phone number: 773-327-9642 ClinicalTrials.gov Identifier: NCT00475605 (IRB Number: 2005-12622)
Childhood Atopic Dermatitis Impact Scale (CADIS)
Back to the top of the page
|